• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?".对《倍利珠单抗作为变应性支气管肺曲霉菌病的一线治疗：真的适用吗？》的回复
Intern Med. 2021 Aug 1;60(15):2521. doi: 10.2169/internalmedicine.6952-20. Epub 2021 Feb 15.
2
Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?贝那利珠单抗作为变应性支气管肺曲霉菌病的一线治疗：真的适用吗？
Intern Med. 2021 Aug 1;60(15):2519. doi: 10.2169/internalmedicine.6807-20. Epub 2021 Feb 15.
3
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan.成功使用贝那鲁肽治疗日本西部灾难性暴雨后发生的变应性支气管肺曲霉病。
Intern Med. 2021 May 1;60(9):1443-1450. doi: 10.2169/internalmedicine.6217-20. Epub 2020 Nov 16.
4
A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.一例变应性支气管肺曲霉病经美泊利单抗成功治疗。
BMC Pulm Med. 2018 Mar 27;18(1):53. doi: 10.1186/s12890-018-0617-5.
5
Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.在对奥马珠单抗无反应的患者中，使用贝那利珠单抗成功治疗变应性支气管肺曲霉病。
J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.
6
An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA).一名患有变应性支气管肺曲霉菌病（ABPA）的哮喘儿童。
Turk J Pediatr. 2018;60(4):446-452. doi: 10.24953/turkjped.2018.04.017.
7
[Biological Treatments in patients with ABPA].[变应性支气管肺曲霉菌病患者的生物治疗]
Tuberk Toraks. 2021 Mar;69(1):84-93. doi: 10.5578/tt.20219910.
8
Allergic bronchopulmonary aspergillosis successfully treated with benralizumab.使用贝那利珠单抗成功治疗变应性支气管肺曲霉病。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1633-1635. doi: 10.1016/j.jaip.2018.11.024. Epub 2018 Dec 1.
9
Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment.在过敏性支气管肺曲霉病中，使用贝那利珠单抗治疗可快速清除对美泊利单抗耐药的支气管黏液栓。
Allergol Int. 2020 Oct;69(4):636-638. doi: 10.1016/j.alit.2020.03.003. Epub 2020 Apr 1.
10
Allergic bronchopulmonary aspergillosis and related allergic syndromes.变应性支气管肺曲霉病和相关变应性综合征。
Semin Respir Crit Care Med. 2011 Dec;32(6):682-92. doi: 10.1055/s-0031-1295716. Epub 2011 Dec 13.

本文引用的文献

1
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan.成功使用贝那鲁肽治疗日本西部灾难性暴雨后发生的变应性支气管肺曲霉病。
Intern Med. 2021 May 1;60(9):1443-1450. doi: 10.2169/internalmedicine.6217-20. Epub 2020 Nov 16.
2
Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.贝那鲁肽对严重未控制哮喘患者晨峰呼气流速的快速作用。
Ann Allergy Asthma Immunol. 2019 May;122(5):478-485. doi: 10.1016/j.anai.2019.02.016. Epub 2019 Feb 23.
3
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.伏立康唑与泼尼松龙单药治疗急性加重期变应性支气管肺曲霉病合并哮喘的随机试验
Eur Respir J. 2018 Sep 18;52(3). doi: 10.1183/13993003.01159-2018. Print 2018 Sep.
4
A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma.一项关于伊曲康唑与泼尼松龙治疗哮喘合并急性变应性支气管肺曲霉病的随机试验。
Chest. 2018 Mar;153(3):656-664. doi: 10.1016/j.chest.2018.01.005. Epub 2018 Jan 11.
5
Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review.变应性支气管肺曲霉病伴或不伴囊性纤维化的抗真菌治疗：系统评价。
Clin Exp Allergy. 2014 Oct;44(10):1210-27. doi: 10.1111/cea.12333.

Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?".

作者信息

Matsuura Hiroaki, Fujiwara Keiichi, Omori Hiroki, Onishi Kiriko, Kuribayashi Tadahiro, Mitsumune Sho, Takigawa Yuki, Kudo Kenichiro, Sato Akiko, Sato Ken, Shibayama Takuo

机构信息

Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.

出版信息

Intern Med. 2021 Aug 1;60(15):2521. doi: 10.2169/internalmedicine.6952-20. Epub 2021 Feb 15.

DOI:10.2169/internalmedicine.6952-20
PMID:33583909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8381187/
Abstract
摘要